183 related articles for article (PubMed ID: 32321450)
1. Reno-protective effects of oral alkalizing agents in chronic kidney disease with aciduria: protocol for a randomized cohort study.
Abe M; Akaishi T; Shoji M; Yamaguchi T; Miki T; Satoh F; Takayama S; Yamasaki S; Kawaguchi K; Sato H; Ishii T; Ito S;
BMC Nephrol; 2020 Apr; 21(1):144. PubMed ID: 32321450
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).
Gaggl M; Cejka D; Plischke M; Heinze G; Fraunschiel M; Schmidt A; Hörl WH; Sunder-Plassmann G
Trials; 2013 Jul; 14():196. PubMed ID: 23826760
[TBL] [Abstract][Full Text] [Related]
3. Oral alkalinizing supplementation suppressed intrarenal reactive oxidative stress in mild-stage chronic kidney disease: a randomized cohort study.
Abe M; Yamaguchi T; Koshiba S; Takayama S; Nakai T; Nishioka K; Yamasaki S; Kawaguchi K; Umeyama M; Masaura A; Ishizawa K; Arita R; Kanno T; Akaishi T; Miyazaki M; Abe T; Tanaka T; Ishii T;
Clin Exp Nephrol; 2024 Jun; ():. PubMed ID: 38872014
[TBL] [Abstract][Full Text] [Related]
4. Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial.
Witham MD; Band MM; Littleford RC; Avenell A; Soiza RL; McMurdo ME; Sumukadas D; Ogston SA; Lamb EJ; Hampson G; McNamee P;
Trials; 2015 Aug; 16():326. PubMed ID: 26231610
[TBL] [Abstract][Full Text] [Related]
5. Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial.
Melamed ML; Horwitz EJ; Dobre MA; Abramowitz MK; Zhang L; Lo Y; Mitch WE; Hostetter TH
Am J Kidney Dis; 2020 Feb; 75(2):225-234. PubMed ID: 31699517
[TBL] [Abstract][Full Text] [Related]
6. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000
[TBL] [Abstract][Full Text] [Related]
7. Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
Goraya N; Simoni J; Sager LN; Madias NE; Wesson DE
Kidney Int; 2019 May; 95(5):1190-1196. PubMed ID: 30846270
[TBL] [Abstract][Full Text] [Related]
8. A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in Chronic Renal Insufficiency (UBI) Study.
Di Iorio B; Aucella F; Conte G; Cupisti A; Santoro D
J Nephrol; 2012; 25(3):437-40. PubMed ID: 21928233
[TBL] [Abstract][Full Text] [Related]
9. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate.
Goraya N; Simoni J; Jo CH; Wesson DE
Clin J Am Soc Nephrol; 2013 Mar; 8(3):371-81. PubMed ID: 23393104
[TBL] [Abstract][Full Text] [Related]
10. Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study.
Chen W; Melamed ML; Hostetter TH; Bauer C; Raff AC; Almudevar AL; Lalonde A; Messing S; Abramowitz MK
BMC Nephrol; 2016 Aug; 17(1):114. PubMed ID: 27495287
[TBL] [Abstract][Full Text] [Related]
11. Oral Sodium Bicarbonate Supplementation Does Not Affect Serum Calcification Propensity in Patients with Chronic Kidney Disease and Chronic Metabolic Acidosis.
Aigner C; Cejka D; Sliber C; Fraunschiel M; Sunder-Plassmann G; Gaggl M
Kidney Blood Press Res; 2019; 44(2):188-199. PubMed ID: 31067546
[TBL] [Abstract][Full Text] [Related]
12. Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial.
BiCARB study group
BMC Med; 2020 Apr; 18(1):91. PubMed ID: 32268897
[TBL] [Abstract][Full Text] [Related]
13. Effect of Bicarbonate on Net Acid Excretion, Blood Pressure, and Metabolism in Patients With and Without CKD: The Acid Base Compensation in CKD Study.
Tyson CC; Luciano A; Modliszewski JL; Corcoran DL; Bain JR; Muehlbauer M; Ilkayeva O; Pourafshar S; Allen J; Bowman C; Gung J; Asplin JR; Pendergast J; Svetkey LP; Lin PH; Scialla JJ
Am J Kidney Dis; 2021 Jul; 78(1):38-47. PubMed ID: 33810868
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral sodium bicarbonate in patients with CKD.
Abramowitz MK; Melamed ML; Bauer C; Raff AC; Hostetter TH
Clin J Am Soc Nephrol; 2013 May; 8(5):714-20. PubMed ID: 23393105
[TBL] [Abstract][Full Text] [Related]
15. Sodium citrate versus sodium bicarbonate for metabolic acidosis in patients with chronic kidney disease: A randomized controlled trial.
Sorohan BM; Obrișcă B; Jurubiță R; Lupușoru G; Achim C; Andronesi A; Frățilă G; Berechet A; Micu G; Ismail G
Medicine (Baltimore); 2024 Mar; 103(10):e37475. PubMed ID: 38457574
[TBL] [Abstract][Full Text] [Related]
16. Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial.
Dubey AK; Sahoo J; Vairappan B; Haridasan S; Parameswaran S; Priyamvada PS
Nephrol Dial Transplant; 2020 Jan; 35(1):121-129. PubMed ID: 30053298
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of potassium citrate and sodium bicarbonate in the alkalinization of urine in homozygous cystinuria.
Fjellstedt E; Denneberg T; Jeppsson JO; Tiselius HG
Urol Res; 2001 Oct; 29(5):295-302. PubMed ID: 11762790
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to Sodium in Patients With CKD-Induced Metabolic Acidosis: Does the Accompanying Anion Matter?
Bushinsky DA
Am J Kidney Dis; 2019 Jun; 73(6):858-865. PubMed ID: 30518477
[TBL] [Abstract][Full Text] [Related]
19. Correction of metabolic acidosis improves insulin resistance in chronic kidney disease.
Bellasi A; Di Micco L; Santoro D; Marzocco S; De Simone E; Cozzolino M; Di Lullo L; Guastaferro P; Di Iorio B;
BMC Nephrol; 2016 Oct; 17(1):158. PubMed ID: 27770799
[TBL] [Abstract][Full Text] [Related]
20. Effect of oral alkali supplementation on progression of chronic kidney disease.
Gaggl M; Sliber C; Sunder-Plassmann G
Curr Hypertens Rev; 2014; 10(2):112-20. PubMed ID: 25549843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
